Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: Mol Pharm. 2019 Feb 15;16(3):1412–1420. doi: 10.1021/acs.molpharmaceut.8b01278

Figure 4.

Figure 4.

(A) Calibration curve of the absorbance of SiR-en at 630 nm; red marker indicates absorbance of SiR-LDFC-trastuzumab. Absorbance and emission spectra of (B) SiR-en and (C) SiR-LDFC-trastuzumab at a protein concentration of 4 nmol/mL (λEx = 630 nm).